Versar, Inc. (NYSE Amex: VSR) announced today the award of a new $5.75 million, five-year contract from the United States Environmental Protection Agency, Office of Pesticide Programs (OPP) to provide scientific and technical support to the Health Effects Division. Versar will perform technical reviews of pesticide human exposure studies and field residue studies. Versar will also provide technical support to assist the EPA in registration of pesticides including assessing ways to reduce occupational and residential exposures to pesticides.

Mr. Tony Otten, CEO of Versar, said, “We are pleased that EPA selected Versar to assist OPP in meeting its pesticide exposure assessment activities. Versar has been deeply involved in supporting the U.S. EPA human exposure efforts for over 30 years and this new award complements other major Versar EPA contracts. We look forward to continuing providing quality scientific services to meet the environmental challenges of the EPA.”

VERSAR, INC., headquartered in Springfield, VA, is a publicly held global project management company providing sustainable solutions to government and commercial clients in construction management, environmental services, munitions response, telecommunications and energy. VERSAR operates a number of web sites, including the corporate Web sites, www.versar.com, www.homelanddefense.com, www.geomet.com; www.viap.com; www.dtaps.com; www.adventenv.com, and www.ppsgb.com.

This press release contains forward-looking information. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be significantly impacted by certain risks and uncertainties described herein and in Versar’s Annual Report on Form 10-K filed with the Securities and Exchange Commission for the year ended June 25, 2010, as updated from time to time in the Company’s periodic filings. The forward-looking statements are made as of the date hereof and Versar does not undertake to update its forward-looking statements.